1. Akinsanya L, Hussain I, Awoniyi D, Usman K. 2008; Leucopenia as presentation of sarcoidosis. Int J Health Sci (Qassim). 2:109–12.
2. Al-Kofahi K, Korsten P, Ascoli C, Virupannavar S, Mirsaeidi M, Chang I, et al. 2016; Management of extrapulmonary sarcoidosis: challenges and solutions. Ther Clin Risk Manag. 12:1623–34. DOI:
10.2147/TCRM.S74476. PMID:
27853374. PMCID:
PMC5106225.
Article
4. Bickett AN, Lower EE, Baughman RP. 2018; Sarcoidosis diagnostic score: a systematic evaluation to enhance the diagnosis of sarcoidosis. Chest. 154:1052–60. DOI:
10.1016/j.chest.2018.05.003. PMID:
29778660. PMCID:
PMC6859250.
6. Park JE, Kim YS, Kang MJ, Kim CJ, Han CH, Lee SM, et al. 2018; Prevalence, incidence, and mortality of sarcoidosis in Korea, 2003-2015: A nationwide population-based study. Respir Med. 144S:S28–34. DOI:
10.1016/j.rmed.2018.03.028. PMID:
29631888.
Article
7. Peña-Garcia JI, Shaikh S, Barakoti B, Papageorgiou C, Lacasse A. 2019; bone marrow involvement in sarcoidosis: an elusive extrapulmonary manifestation. J Community Hosp Intern Med Perspect. 9:150–4. DOI:
10.1080/20009666.2019.1575688. PMID:
31061693. PMCID:
PMC6487444.
Article
9. Judson MA, Costabel U, Drent M, Wells A, Maier L, Koth L, et al. 2014; The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool. Sarcoidosis Vasc Diffuse Lung Dis. 31:19–27.
12. Yanardağ H, Pamuk GE, Karayel T, Demirci S. 2002; bone marrow involvement in sarcoidosis: an analysis of 50 bone marrow samples. Haematologia (Budap). 32:419–25.
13. Statement on sarcoidosis. 1999; Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 160:736–55.
14. Eid A, Carion W, Nystrom JS. 1996; Differential diagnoses of bone marrow granuloma. West J Med. 164:510–5.